$27.92+0.24 (+0.87%)
At close: Nov 16, 2026, 4:00 PM ET· NYSE · USD
Enovis (ENOV) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue compounds ~12.0%/yr (FY21→FY25), net margin −52.7%.
The four lines that matter · FY21–FY25
Revenue ($M)▲6.7%
2,248.0
FY21→FY25CAGR +12.0%/yr
Net income ($M)▼43.5%
−1,183.6
one-off year: see footnoteCAGR —
Free cash flow ($M)—
19.9
FY21→FY25CAGR −47.0%/yr
Diluted EPS▼39.0%
−20.75
buyback-liftedCAGR —
What the receipts whisper · what a headline number hides
Share count
−64.5%
161.3mn → 57.2mn diluted shares since FY21. Part of EPS growth is the shrinking denominator. Watch net income too.
Capex
$197.4M
steady at 8.8% of revenue (+9.2% YoY).
What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)
-53¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Margin trend · direction beats level Gross Operating Net
Over this window: gross 54.5% → 59.8%. Net margin -52.7% is below the sector median.
The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 2,306.4 | 2,248.0 | 2,107.6 | 1,707.2 | 1,563.1 | 1,426.2 | ▲6.7% | +12.0% |
Cost of revenue | 892.4 | 902.8 | 926.9 | 716.4 | 693.7 | 648.5 | ▼2.6% | +8.6% |
Gross profit | 1,414.0 | 1,345.3 | 1,180.8 | 990.8 | 869.4 | 777.7 | ▲13.9% | +14.7% |
Research & development | 125.9 | 120.3 | 91.3 | 75.3 | 60.8 | 49.1 | ▲31.8% | +25.1% |
Selling, general & admin | 1,076.4 | 1,070.2 | 1,027.4 | 830.3 | 772.9 | 665.8 | ▲4.2% | +12.6% |
Total operating expenses | 1,888.9 | 2,469.5 | 1,956.5 | 1,056.5 | 940.6 | 840.5 | ▲26.2% | +30.9% |
Operating incomefeeds ROC rank | −474.9 | −1,124.2 | −775.7 | −65.7 | −71.2 | −62.8 | ▼44.9% | — |
Other income, net | −27.0 | −35.2 | −47.2 | −1.4 | 69.1 | −59.0 | — | — |
Pretax income | −501.9 | −1,159.4 | −822.9 | −67.1 | −2.1 | −121.8 | ▼40.9% | — |
Income tax | 25.1 | 22.3 | 4.5 | −13.3 | 36.1 | −19.5 | ▲396.3% | −14.9% (22→25) |
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings | −526.5 | −1,183.6 | −824.8 | −32.7 | −11.8 | 76.3 | ▼43.5% | — |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | −9.25 | −20.75 | −14.93 | −0.61 | −0.25 | 1.40 | ▼39.0% | — |
Diluted shares (mn) | 57.69 | 57.25 | 56.96 | 54.62 | 54.33 | 161.33 | ▲0.5% | −22.8% |
| Margins | ||||||||
Gross margin42nd pct in Healthcare | 61.3% | 59.8% | 56.0% | 58.0% | 55.6% | 54.5% | ▲3.8pp | +5.3pp |
Operating margin | −20.6% | −50.0% | −36.8% | −3.8% | −4.6% | −4.4% | ▼13.2pp | −45.6pp |
Net margin22nd pct in Healthcare | −22.8% | −52.7% | −39.1% | −1.9% | −0.8% | 5.3% | ▼13.5pp | −58.0pp |
† TTM = trailing four quarters through 2026-10-02.FY21 effective tax rate was 16% vs a −1% norm for this window, likely a one-time item; see the filing.FY22 effective tax rate was −1746% vs a −1% norm for this window, likely a one-time item; see the filing.
5 more years of statements and CSV export are on Premium, and 12 more on Ultimate.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
These lines feed the tenet checklists: see which gates passTenets →Margins & returns continue as sector-ranked ratiosStatistics →
Annual report filed 2026-02-26 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Enovis' revenue last fiscal year?
Enovis reported revenue of $2,248.0M in fiscal 2025, up 6.7% from fiscal 2024.
What was Enovis' net income?
Enovis reported net income of −$1,183.6M in fiscal 2025, a net margin of −52.7%.
Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

